PODOLSKI JOSEPH 4
4 · REPROS THERAPEUTICS INC. · Filed Sep 7, 2012
Insider Transaction Report
Form 4
PODOLSKI JOSEPH
DirectorChief Executive Officer
Transactions
- Award
Stock Option
2012-09-05+50,000→ 50,000 totalExercise: $14.23Exp: 2022-09-05→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as follows: 10,000 shares on the date hereof based on completion of the recent private placement, and the remaining 40,000 shares based upon achievement of various clinical development and other milestones.